How Network Bio and NVIDIA plan to turn cell-free RNA into disease-spanning medical intelligence
Network Bio and NVIDIA are scaling a cfRNA foundation model for disease detection, biomarker discovery and drug development across biobanks.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Aztron Medtech just doubled TendMIN’s U.S. procedure count. Can the next financing round turn early adoption into scale?
Aztron Medtech wins a Taiwan Presidential Award as TendMIN passes 200 U.S. procedures and the company prepares its next financing round.
Medical Devices & Diagnostics
Cardio Diagnostics now controls its own cardiac test lab, but can CLIA certification unlock meaningful scale?
Cardio Diagnostics starts in-house Epi+Gen CHD and PrecisionCHD processing in Iowa. See what CLIA certification means for margins and adoption.
Medical Devices & Diagnostics
ATEV beats AV fistula in Phase 3 dialysis trial as Humacyte prepares FDA filing
Humacyte’s ATEV beats AV fistula in Phase 3 dialysis access testing as peer-reviewed V007 data strengthen its planned 2026 FDA filing.
Medical Devices & Diagnostics
Can one blood test reveal which cells are aging fastest? Vero brings Stanford Cell Clock into OrganAge
Vero adds Stanford Cell Clock technology to OrganAge ahead of a 2027 rollout, while clinical validation remains the key commercial test.
Medical Devices & Diagnostics
Gemelli Biotech IBS-Smart study finds lower diagnostic costs in patients with suspected IBS
Gemelli Biotech’s IBS-Smart and Trio-Smart were linked to lower captured diagnostic costs in a 219-patient IBS study, but causality remains unproven.
Medical Devices & Diagnostics
InformedDNA has now divested two businesses in 2026. Why is everything pointing toward DNAimpact?
InformedDNA divests its genetic testing utilization management unit to Zyter, sharpening its DNAimpact precision health strategy after two 2026 deals.
Medical Devices & Diagnostics
FDA clears Vesalio pVasc NET for peripheral mechanical thrombectomy
The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Vesalio for pVasc NET, a peripheral mechanical thrombectomy device that combines a self-expanding clot retriever with a fine-pore, dual-layer filter positioned at its distal end. The FDA classified the device as substantially equivalent through the Special 510(k) pathway on August 5, 2026. Vesalio
Medical Devices & Diagnostics
FDA clears Samsung Galaxy Buds software as an over-the-counter hearing aid
Samsung Electronics has received United States Food and Drug Administration (FDA) clearance for software that allows compatible Galaxy Buds to function as self-fitting, over-the-counter hearing aids for adults with perceived mild to moderate hearing impairment. The Hearing Aid Feature will initially be available on Galaxy Buds3 Pro and Galaxy Buds4 Pro in the United States
Medical Devices & Diagnostics
What FDA’s blue-light cystoscopy reclassification could mean for Photocure and Cysview
FDA’s Class II proposal could lower a major equipment barrier for Photocure’s Cysview. See what the regulatory shift could mean for US adoption.